MMP7 and breast carcinoma: They clearly showed that high MMP-7-expressing breast cancer had relatively low phosphatase and tensin homolog (PTEN) levels both in clinical cases and cell lines, and the high levels of MMP-7 expression and enzymatic activity were abrogated by inhibition of phosphoinositide 3-kinase (PI3K), which is as main target of PTEN.